| The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer Nature Medicine, 1-11, 2021 | 206* | 2021 |
| Basal-like breast cancer: molecular profiles, clinical features and survival outcomes HH Milioli, I Tishchenko, C Riveros, R Berretta, P Moscato BMC medical genomics 10, 1-17, 2017 | 127 | 2017 |
| MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer N Portman, HH Milioli, S Alexandrou, R Coulson, A Yong, KJ Fernandez, ... Breast Cancer Research 22, 1-17, 2020 | 55 | 2020 |
| Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression B Heng, AA Bilgin, DB Lovejoy, VX Tan, HH Milioli, L Gluch, ... Breast Cancer Research 22, 1-14, 2020 | 45 | 2020 |
| The discovery of novel biomarkers improves breast cancer intrinsic subtype prediction and reconciles the labels in the metabric data set HH Milioli, R Vimieiro, C Riveros, I Tishchenko, R Berretta, P Moscato PLoS One 10 (7), e0129711, 2015 | 42 | 2015 |
| Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion HH Milioli, KS Sousa, R Kaviski, NCDS Oliveira, CDA Urban, RS De Lima, ... Cancer Genomics & Proteomics 12 (2), 89-101, 2015 | 39 | 2015 |
| Non-canonical AR activity facilitates endocrine resistance in breast cancer KM Chia, H Milioli, N Portman, G Laven-Law, R Coulson, A Yong, ... Endocrine-related cancer 26 (2), 251-264, 2019 | 36 | 2019 |
| Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets HH Milioli, S Alexandrou, E Lim, CE Caldon Endocrine-related cancer 27 (5), R93-R112, 2020 | 32 | 2020 |
| Comparative proteomic analysis of ductal and lobular invasive breast carcinoma NC Oliveira, TH Gomig, HH Milioli, F Cordeiro, GG Costa, CA Urban, ... Genet Mol Res 15 (2), 1-10, 2016 | 25 | 2016 |
| Iteratively refining breast cancer intrinsic subtypes in the METABRIC dataset HH Milioli, R Vimieiro, I Tishchenko, C Riveros, R Berretta, P Moscato BioData mining 9, 1-8, 2016 | 24 | 2016 |
| Extensive transcriptomic and genomic analysis provides new insights about luminal breast cancers I Tishchenko, HH Milioli, C Riveros, P Moscato PloS one 11 (6), e0158259, 2016 | 24 | 2016 |
| Enhancing metabolite coverage in MALDI-MSI using laser post-ionisation (MALDI-2) JC McKinnon, HH Milioli, CA Purcell, CL Chaffer, B Wadie, T Alexandrov, ... Analytical Methods 15 (34), 4311-4320, 2023 | 11 | 2023 |
| The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer J Achinger-Kawecka, C Stirzaker, N Portman, E Campbell, KM Chia, Q Du, ... Nature Structural & Molecular Biology 31 (3), 498-512, 2024 | 8 | 2024 |
| Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen-and prolactin-receptors in breast cancer F Shehadeh-Tout, HH Milioli, S Roslan, PJ Jansson, M Dharmasivam, ... Pharmacological Research 193, 106806, 2023 | 7 | 2023 |
| Epigenetic therapy suppresses endocrine-resistant breast tumour growth by re-wiring ER-mediated 3D chromatin interactions J Achinger-Kawecka, C Stirzaker, KM Chia, N Portman, E Campbell, Q Du, ... bioRxiv, 2021.06. 21.449340, 2021 | 6 | 2021 |
| Targeting phenotypic plasticity prevents metastasis and the development of chemotherapy-resistant disease BP San Juan, S Hediyeh-Zadeh, L Rangel, HH Milioli, V Rodriguez, ... MedRxiv, 2022.03. 21.22269988, 2022 | 4 | 2022 |
| An innovative non-hormonal strategy targeting redox active metals to down-regulate estrogen-, progesterone-, androgen-and prolactin-receptors in breast cancer F Shehadeh-Tout, HH Milioli, S Roslan, PJ Jansson, M Dharmasivam, ... bioRxiv, 2023.02. 02.526543, 2023 | 3 | 2023 |
| Increased prevalence of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer Iscience 27 (7), 2024 | 2 | 2024 |
| Epigenetic therapy targets the 3D epigenome in endocrine-resistant breast cancer J Achinger-Kawecka, C Stirzaker, N Portman, E Campbell, K Chia, Q Du, ... | 2 | 2021 |
| Abstract GS2-03: The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer E Lim, TA Hickey, LA Selth, KM Chia, HH Milioli, D Roden, G Laven-Law, ... Cancer Research 80 (4 Supplement), GS2-03-GS2-03, 2020 | 2 | 2020 |
Pablo MoscatoProfessor and Deputy Head of School (Research), SIPS, The University of NewcastleVerified email at newcastle.edu.au
